Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions

 

View bio business grants awarded by year.
Amir Naqwi, PhD
We are proposing the development of an airway cell sprayer that would be included in the instrument channel of a bronchoscope for depositing viable…
2020-2021
Maria Athanasiou, PhD
Building on successful primate model studies, MarPam Pharma is developing a one‐time treatment for durable remission of HIV in the absence of…
2020-2021
Patrick Walsh, MS
The goal of this grant is to bring Anatomi Corp's Chrono™ Platform to market. A small portion of this funding will offset overhead costs associated…
2019-2020
Neil Otto, PhD
The ultimate goal is to provide our gene transfer transposon/transposase platforms to the rapidly growing field of gene modified cell therapy. B‐…
2019-2020
Timothy O'Brien, DVM, PhD
We have developed a novel technology that induces human stem cells to form cartilage. In this project we aim to take the first steps in developing…
2019-2020
Richard Murphy, General Manager
The aim of this grant proposal is to develop cardiovascular devices at Vascudyne with regenerative engineered tissue technology licensed from the…
2019-2020
Ohad Gafni, PhD
Our goal is to engineer a humanized swine model that carries key human cytokines, this strategy will provide the immunology field a high capacity…
2019-2020
Dominique Davidow, PhD
Perfusion decellularization and recellularization are patented technologies owned by Miromatrix Medical Inc. Upon complete removal of cellular…
2019-2020
Frank H. Burton, PhD
This project is performing translational studies on a wound-healing accelerant that has been provisionally patented. Animal studies showed that…
2019-2020
Vanesa Alonso-Camino, PhD
We plan to isolate and expand glioblastoma (GBM) cells from commercially available fresh tumor tissue. These cells will be used to create tumor…
2019-2020
Timothy D. O'Brien, DVM, PhD
Our overall goal is to develop a cell therapy product for the treatment of Parkinson's disease.  In the present proposal we will evaluate critical…
2018-2019
Joseph S. Uzarski, PhD
Miromatrix is working to create a new source of kidney grafts for thousands of patients suffering from kidney failure who are wait-listed for…
2018-2019